Synthetic analogues of migrastatin that inhibit mammary tumor metastasis in mice.

Tumor metastasis is the most common cause of death in cancer patients. Here, we show that two, fully synthetic migrastatin analogues, core macroketone and core macrolactam, are potent inhibitors of metastasis in a murine breast tumor model. Administration of these readily accessible compounds nearly completely inhibits lung metastasis of highly metastatic mammary carcinoma cells. Treatment of tumor cells with core macroketone and core macrolactam blocks Rac activation, lamellipodia formation, and cell migration, suggesting that these chemical compounds interfere with the invasion step of the metastatic process. These compounds also inhibit the migration of human metastatic breast cancer cells, prostate cancer cells, and colon cancer cells but not normal mammary-gland epithelial cells, fibroblasts, and leukocytes. These data demonstrate that the macroketone and macrolactam core structures are specific small-molecule inhibitors of tumor metastasis. These compounds or their analogues could potentially be used in cancer-therapy strategies.

[1]  Xiaojing Ma,et al.  Regulation of interleukin‐12 gene expression and its anti‐tumor activities by prostaglandin E2 derived from mammary carcinomas , 2004, Journal of leukocyte biology.

[2]  Jon T. Njardarson,et al.  The migrastatin family: discovery of potent cell migration inhibitors by chemical synthesis. , 2004, Journal of the American Chemical Society.

[3]  Xin-Yun Huang,et al.  Discovery of potent cell migration inhibitors through total synthesis: lessons from structure-activity studies of (+)-migrastatin. , 2004, Journal of the American Chemical Society.

[4]  G. Borisy,et al.  Cell Migration: Integrating Signals from Front to Back , 2003, Science.

[5]  I. Fidler,et al.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.

[6]  P. Cole,et al.  Csk, a critical link of g protein signals to actin cytoskeletal reorganization. , 2002, Developmental cell.

[7]  C. Starks,et al.  Migrastatin and a new compound, isomigrastatin, from Streptomyces platensis. , 2002, The Journal of antibiotics.

[8]  Peijun Zhang,et al.  Activation of Arp2/3 complex-mediated actin polymerization by cortactin , 2001, Nature Cell Biology.

[9]  M. Imoto,et al.  Migrastatin, a new inhibitor of tumor cell migration from Streptomyces sp. MK929-43F1. Taxonomy, fermentation, isolation and biological activities. , 2000, The Journal of antibiotics.

[10]  M. Imoto,et al.  Migrastatin, a novel 14-membered lactone from Streptomyces sp. MK929-43F1. , 2000, The Journal of antibiotics.

[11]  S. Weed,et al.  Translocation of cortactin to the cell periphery is mediated by the small GTPase Rac1. , 1998, Journal of cell science.

[12]  S. Ostrand-Rosenberg,et al.  Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines. , 1998, Cancer research.

[13]  Anne J. Ridley,et al.  The small GTP-binding protein rac regulates growth factor-induced membrane ruffling , 1992, Cell.

[14]  F. Miller,et al.  Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. , 1992, Cancer research.